Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Beyond Valves: What is the Next Frontier in SH Innovation?

Presenter: Jamie McCabe

November 14, 2025

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

Presentation Miami Valves 2024

Where Did The Valve Go?

Presenter: Venkatesh Alapati

February 03, 2024

Presentation Miami Valves 2024

Surgical Patient Prosthesis Mismatch with Valve Degeneration

Presenter: Som Bailey

February 01, 2024

Presentation STS 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presenter: Jad Malas

January 27, 2024

Presentation Controversies and Advances 2023

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Presenter: Michael Mack

November 30, 2023

Presentation Miami Valves 2023

Cephea Implantation in Native Mitral Valve

Presenter: Azeem Latib

February 04, 2023

Presentation Miami Valves 2023

Newer transseptal crossing techniques

Presenter: Venkatesh Alapati

February 04, 2023

Presentation Miami Valves 2023

Unmet needs and next step The next generation Watchman FLX

Presenter: Saibal Kar

February 04, 2023

Presentation Interventional Complications 2022

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Presenter: Frederick Welt

July 15, 2022

Presentation Interventional Complications 2022

LVOT obstruction post TMVR

Presenter: Adam Greenbaum

July 15, 2022

Presentation Interventional Complications 2022

Transcatheter Mitral Valve Edge to Edge Repair: Argh, my gradient is 8 mmHg!

Presenter: Chad Rammohan

July 15, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

Presentation Controversies and Advances 2021

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Presenter: Raj R. Makkar

December 03, 2021

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Advertisement

Beyond Valves: What is the Next Frontier in SH Innovation?

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Short Methodology Insight - NOTION-2

Where Did The Valve Go?

Surgical Patient Prosthesis Mismatch with Valve Degeneration

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Cephea Implantation in Native Mitral Valve

Newer transseptal crossing techniques

Unmet needs and next step The next generation Watchman FLX

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

LVOT obstruction post TMVR

Transcatheter Mitral Valve Edge to Edge Repair: Argh, my gradient is 8 mmHg!

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Guidelines for the Management of Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content